FB Nasdaq FB Facebook

Healthcare Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Bristol-Myers Squib (NYSE:BMY), Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

Congress jumped into the health care game (again) by “complaining” that Gilead Sciences, Inc. (NASDAQ:GILD)’s hepatitis drug was priced too high. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was 3.92% in last session and finished the day at $73.64. Traded volume was 19.50million shares in the last session and the average volume of the stock remained 13.29million shares. The beta of the stock remained 0.55. Gilead … Continue reading Healthcare Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Bristol-Myers Squib (NYSE:BMY), Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

ARM Holdings in Line to Meet Full Year Guidance After Solid Quarter

ARM Holdings reported strong third-quarter earnings and gave investors a solid, but not spectacular, fourth-quarter outlook that was relatively in line with our expectations. We will maintain our moat rating for ARM but may raise our fair value estimate by about 10%. Nonetheless, we still believe the company’s stock price reflects overly optimistic assumptions about long-term royalty growth, particularly from PCs and servers. ARM’s revenue … Continue reading ARM Holdings in Line to Meet Full Year Guidance After Solid Quarter

BBRY NASDAQ BBRY Blackberry

BlackBerry’s Q4 Loss Narrower than Expected

BlackBerry (BBRY, BB.TO) reported a Q4 adjusted loss of $0.08 per share, better than expectations of a loss of $0.54 per share, if comparable. Revenue was $976 million, down 64% from $2.7 billion in the year ago quarter, and below the analyst consensus of $1.2 billion on Capital IQ. During Q4, the company recognized hardware revenue on approximately 1.3 million BlackBerry smartphones compared to approximately … Continue reading BlackBerry’s Q4 Loss Narrower than Expected

FB Nasdaq FB Facebook

HomeAway Shares Down 1% After-Hours

Shares of HomeAway (NASDAQ:AWAY) are dipping in after-hours trade as the online vacation rental company said it intends to offer $350 million aggregate principal amount of convertible senior notes due 2019 in a private placement to qualified institutional buyers, as well as expects to grant the initial purchasers of the notes a 30-day option to purchase up to an additional $52.5 million aggregate principal amount … Continue reading HomeAway Shares Down 1% After-Hours

FB Nasdaq FB Facebook

SciQuest Dips 1% on 3 Million Share Offering

SciQuest (NASDAQ:SQI) said it is starting an underwritten public offering of 3,000,000 shares of common stock pursuant to an effective shelf registration statement. The last reported sale price of the company’s common stock on March 21, 2014 was $30.41 per share. The company also intends to grant the underwriters an option to purchase up to 450,000 additional shares of common stock. The company expects to … Continue reading SciQuest Dips 1% on 3 Million Share Offering

Stocks Moving On Analyst Actions

Dover (DOV) was started with a Neutral rating at Goldman Sachs, and shares nosed down less than 1%. Goldman placed an $88 price target on the shares of the diversified manufacturer. In afternoon trade, DOV was off 0.33% to $81.20. Insulet (PODD) was started with a buy rating at Sterne Agee. Shares fell less than 1%. vSterne Agee set a $61 price target on the medical device … Continue reading Stocks Moving On Analyst Actions